GSK

GSK

Market cap $81.5B

787 hedge funds and large institutions have $11B invested in GSK in 2018 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 260 increasing their positions, 294 reducing their positions, and 54 closing their positions.

New

Increased

Maintained

Reduced

Closed

2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

787

Holders Change

–

Holders Change %

% of All Funds

18.02%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+7.14%

% of All Funds

0.34%

New

Increased

260

Reduced

294

Closed

Calls

$123M

Puts

$87.4M

Net Calls

+$36M

Net Calls Change

-$28.6M

Top Buyers

1	Arrowstreet Capital Boston, Massachusetts	+$215M
2	Renaissance Technologies New York	+$32.4M
3	Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts	+$29.1M
4	EVM Eaton Vance Management Boston, Massachusetts	+$25.4M
5	Morgan Stanley New York	+$24M

Top Sellers

1	Bank of New York Mellon New York	-$152M
2	Deutsche Bank Frankfurt Am Main Ge, Germany	-$70.8M
3	Royal Bank of Canada Toronto, Ontario, Canada	-$39.6M
4	Millennium Management New York	-$30.4M
5	CIM Confluence Investment Management St. Louis, Missouri	-$22M

#	Name	Holding	Trade Value	Shares Change	Shares Change %
376	BAM 376 Bruderman Asset Management Locust Valley, New York	$610K	-$6.23M	-123,935	-91%
377	CAM 377 Columbia Asset Management Ann Arbor, Michigan	$608K	-$50.2K	-1,000	-8%
378	RA 378 Rational Advisors Huntington, New York	$608K	+$233K	+4,640	+62%
379	SSG 379 Summit Securities Group New York	$607K	+$358K	+7,120	+144%
380	RHBC 380 R.H. Bluestein & Co Birmingham, Michigan	$603K	–	–	–
381	SF 381 Synovus Financial Columbus, Georgia	$602K	-$18.9K	-377	-3%
382	SWM 382 SeaCrest Wealth Management Purchase, New York	$601K	+$15.7K	+312	+3%
383	SWP 383 Stratos Wealth Partners Beachwood, Ohio	$591K	+$15.5K	+309	+3%
384	IWM 384 IHT Wealth Management Chicago, Illinois	$591K	+$46.6K	+929	+9%
385	CTC 385 Central Trust Company Jefferson City, Missouri	$588K	-$42.3K	-843	-7%
386	IA 386 IFG Advisory Atlanta, Georgia	$584K	+$903	+18	+0.2%
387	MHI 387 Miller Howard Investments Kingston, New York	$580K	-$144K	-2,860	-20%
388	SCM 388 Shelton Capital Management Denver, Colorado	$574K	-$214K	-4,260	-27%
389	ONST 389 Old North State Trust Greensboro, North Carolina	$574K	+$574K	+11,443	New
390	SLT 390 St Louis Trust Saint Louis, Missouri	$558K	–	–	–
391	WA 391 WealthTrust Axiom Wayne, Pennsylvania	$552K	+$124K	+2,480	+29%
392	GWM 392 Geneos Wealth Management Englewood, Colorado	$544K	+$75.7K	+1,509	+16%
393	CA 393 Cetera Advisors Denver, Colorado	$543K	+$333K	+6,680	+158%
394	HT 394 HighTower Trust Houston, Texas	$539K	-$100K	-2,000	-16%
395	TIA 395 Trust Investment Advisors Indianapolis, Indiana	$539K	-$10K	-200	-2%
396	PT 396 Plimoth Trust Plymouth, Massachusetts	$536K	-$8.85K	-176	-2%
397	PFSC 397 Peoples Financial Services Corp Dunmore, Pennsylvania	$536K	–	–	–
398	BAC 398 Boys Arnold & Co Asheville, North Carolina	$526K	–	–	–
399	IWP 399 Icon Wealth Partners Houston, Texas	$524K	+$28.2K	+562	+6%
400	GF 400 Gabelli Funds Rye, New York	$522K	–	–	–

GSK GSK Market cap $81.5B

Top Buyers

Top Sellers

GSK

GSK

Market cap $81.5B